REDUCE LAP-HF II interatrial shunt trial: neutral, but necessary
- PMID: 35120591
- DOI: 10.1016/S0140-6736(22)00108-8
REDUCE LAP-HF II interatrial shunt trial: neutral, but necessary
Conflict of interest statement
We declare no competing interests.
Comment on
-
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.Lancet. 2022 Mar 19;399(10330):1130-1140. doi: 10.1016/S0140-6736(22)00016-2. Epub 2022 Feb 1. Lancet. 2022. PMID: 35120593
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous